drugset / Trial / NCT05664815
Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to demonstrate, during the first standard surgical management of patients with stage II MRONJ, the effect of the implantation of a cryopreserved hAM on the maxillomandibular bone, on the healing of the oral mucosa.
Timeline
- Start
- 2023-09-22
- Primary completion
- 2025-09
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human Amniotic Membrane | Unknown | — | — |